Literature DB >> 12440454

Haloperidol decanoate doses of 200, 100, or 50 mg/month reduced symptomatic exacerbations more than a 25 mg/month dose in schizophrenia.

Marie-Josée Marois1, Marc-André Roy.   

Abstract

Entities:  

Year:  2002        PMID： 12440454     DOI： 10.1136/ebmh.5.4.113

Source DB:  PubMed          Journal:  Evid Based Ment Health        ISSN： 1362-0347


× No keyword cloud information.
  1 in total

1.  Effectiveness of 1-year treatment with long-acting formulation of aripiprazole, haloperidol, or paliperidone in patients with schizophrenia: retrospective study in a real-world clinical setting.

Authors:  Rosaria Di Lorenzo; Paola Ferri; Michela Cameli; Sergio Rovesti; Chiara Piemonte
Journal:  Neuropsychiatr Dis Treat       Date:  2019-01-07       Impact factor: 2.570
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.